1975
DOI: 10.1002/chin.197535392
|View full text |Cite
|
Sign up to set email alerts
|

ChemInform Abstract: STEREOSPECIFIC SYNTHESIS OF THE 6BETA‐HYDROXY METABOLITES OF NALTREXONE AND NALOXONE

Abstract: Naltrexon (Ia) und Naloxon (IIa) werden mit Formamidin‐sulfinsäure zu (Ib) bzw. (IIb) reduziert.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0
1

Year Published

1980
1980
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 1 publication
0
6
0
1
Order By: Relevance
“…It is possible that pharmacological actions of 6-alpha-and 6-beta-naloxol differ from naloxone in other respects. For example, there is some evidence that 6-alpha-naloxol is a weak agonist (Chatterjie and Inturrisi, 1975). Such activity might result in less CPA following morphine pretreatment by substituting for morphine and alleviating morphine withdrawal.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is possible that pharmacological actions of 6-alpha-and 6-beta-naloxol differ from naloxone in other respects. For example, there is some evidence that 6-alpha-naloxol is a weak agonist (Chatterjie and Inturrisi, 1975). Such activity might result in less CPA following morphine pretreatment by substituting for morphine and alleviating morphine withdrawal.…”
Section: Discussionmentioning
confidence: 99%
“…Such activity might result in less CPA following morphine pretreatment by substituting for morphine and alleviating morphine withdrawal. However, 6-beta-naloxol was reported to have no such partial agonist activity (Chatterjie and Inturrisi, 1975) and naloxone itself has been reported to be a weak agonist (Fukuda et al, 1998;Liu and Prather, 2001;Wang et al, 2004) making such an explanation unlikely. Since the receptor binding profiles of 6-alphaand 6-beta-naloxol are incomplete, it is possible that these drugs interact, differentially from naloxone, with other, non-mu opioid, receptor systems resulting in counteraction of the morphine enhancement of both CPA and withdrawal jumping.…”
Section: Discussionmentioning
confidence: 99%
“…The tricyclic ring system of the antidepressant drug amitriptyline has inspired many endeavors toward molecular modifications.1'2 During an SAR study of tetracyclic analogues, an attempt was made to synthesize 7Hbenzo [5,6]cycloocta[l,2,3-de]naphthalen-7-one (l). 3 We report an intramolecular Friedel-Crafts acylation of 3benzyl-l/f,3H-naphtho[l, 8-cd]pyran-l-one (2) in polyphosphoric acid (PPA).…”
mentioning
confidence: 99%
“…ΔGmmgbsa values determined using the MMGBSA method showed that the binding affinity was energetically more favorable for NTX than for its derivatives, explaining the higher potency of NTX compared with NTXOL, which is also a MOR antagonist but a hundred times less potent than NTX [32]. However, despite NTXOL showing a lower affinity, many other factors contribute to its lower potency, such as entropic effects, which we didn't explore with the MMGBSA approach.…”
Section: Discussionmentioning
confidence: 97%
“…The major metabolite of NTX in humans and other animal species is 6-β-naltrexol (NTXOL), and 2-hydroxy-3-O-methylnaltrexol (HMNTXOL) is another minor metabolite. NTXOL is also an opioid receptor agonist but is hundreds of times less potent than NTX at the mu-receptor [32]. Molecular modeling analysis based on molecular mechanics and semi-empirical calculations has shown that NTXOL and NTX share a comparable surface area and volume, indicating that both substrates may have a similar affinity for the same binding site in opioid receptors [33].…”
Section: Introductionmentioning
confidence: 99%